Global Hemostasis & Tissue Sealing Agents Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product Type;

Topical Hemostats - Active, Mechanical & Flowable, Adhesives & Tissue Sealing Agents - Natural Tissue Sealants, Synthetic Tissue Sealants and Adhesion Barrier Products.

By End User;

Hospitals, Ambulatory Surgical Centers and Home Care Settings.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn439563457 Published Date: June, 2024 Updated Date: July, 2024

Introduction

Global Hemostasis & Tissue Sealing Agents Market (USD Million), 2020 - 2030

In the year 2023, the Global Hemostasis & Tissue Sealing Agents Market was valued at USD 3,343.35 million. The size of this market is expected to increase to USD 5,354.66 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.0%.

The Global Hemostasis and Tissue Sealing Agents Market is a rapidly evolving sector within the medical field, driven by advancements in surgical procedures and the increasing prevalence of chronic diseases requiring surgical interventions. Hemostasis agents are critical for controlling bleeding during surgeries, while tissue sealing agents facilitate the closure of wounds and support healing processes. The market encompasses a variety of products, including fibrin sealants, gelatin-based sealants, and synthetic agents, each tailored to specific medical needs and surgical contexts. Innovations in biomaterials and the growing demand for minimally invasive surgeries are propelling the development and adoption of these agents globally.

A significant factor contributing to the market's growth is the rising number of surgical procedures worldwide. This surge is attributed to the aging population, which is more susceptible to conditions requiring surgical intervention, such as cardiovascular diseases, orthopedic disorders, and cancer. Increased awareness and diagnosis of these conditions have led to more frequent surgical treatments. Consequently, the demand for effective hemostasis and tissue sealing agents has escalated, as these products enhance surgical outcomes by reducing complications associated with excessive bleeding and poor wound healing.

Technological advancements in the design and application of hemostasis and tissue sealing agents are enhancing their efficacy and safety profiles. Companies in this market are investing in research and development to create next-generation products that offer better biocompatibility, faster action, and easier application. These advancements not only improve patient outcomes but also reduce the time and costs associated with surgical procedures. As healthcare systems globally continue to emphasize cost-efficiency and patient safety, the adoption of advanced hemostasis and tissue sealing agents is expected to rise, driving further market expansion.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Hemostasis & Tissue Sealing Agents Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Surgical advancements
        2. Aging population
        3. Chronic diseases
        4. Minimally invasive
      2. Restraints
        1. Regulatory hurdles
        2. Limited awareness
        3. Reimbursement issues
        4. Technical complexity
      3. Opportunities
        1. Aging Population
        2. Surgical Demand
        3. Technological Advancements
        4. Chronic Diseases
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Hemostasis & Tissue Sealing Agents Market, By Product Type, 2020- 2030 (USD Million)
      1. Topical Hemostats
        1. Active
        2. Mechanical
        3. Flowable
      2. Adhesives & Tissue Sealing Agents
        1. Natural Tissue Sealants
        2. Synthetic Tissue Sealants
        3. Adhesion Barrier Products
    2. Global Hemostasis & Tissue Sealing Agents Market, By End User, 2020- 2030 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Home Care Settings
    3. Global Hemostasis & Tissue Sealing Agents Market, By Geography, 2020- 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Johnson & Johnson
      2. CryoLife Inc.
      3. Advance Medical Solution (AMS) Group Plc.
      4. Cohera Medical Inc.
      5. Integra Life Sciences Corporation
      6. Pfizer Inc.
      7. BD
      8. Baxter
      9. HyperBranch Medical Technology
      10. Biomet Inc
      11. B Braun Medical Inc
      12. Smith & Nephew
  7. Analyst Views
  8. Future Outlook of the Market